Latest news
13-12-2022 - Letters of Intent Invited for ADDF/AFTD Treat Frontotemporal Degeneration (FTD) Fund
Funding for clinical trials of novel or repurposed drugs for frontotemporal degeneration and related disorders.
Launched in 2016, the Treat FTD Fund is jointly funded by the Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD) to provide critical funding for early stage clinical trials.
[...]